Share Price and Basic Stock Data
Last Updated: November 7, 2025, 6:38 pm
| PEG Ratio | 0.25 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Bhaskar Agrochemicals Ltd operates in the agrochemicals and pesticides sector, focusing on enhancing agricultural productivity. The company reported a market capitalization of ₹56.8 Cr and a share price of ₹109. Over the past financial years, Bhaskar Agrochemicals has shown a fluctuating revenue trend. For instance, sales stood at ₹55 Cr for the fiscal year ending March 2023, a decline from ₹62 Cr in March 2022. However, the company reported a significant rebound with sales increasing to ₹67 Cr in March 2024 and projected to reach ₹91 Cr in March 2025. Quarterly sales have also demonstrated variability, with a notable rise to ₹29.55 Cr in September 2023, following a dip in the preceding quarters. This volatility can be attributed to seasonal factors and market dynamics within the agrochemical sector. Overall, the revenue trajectory suggests a potential recovery, driven by increasing demand for agrochemical products in India.
Profitability and Efficiency Metrics
Profitability metrics for Bhaskar Agrochemicals indicate a mixed performance in recent periods. The company recorded a net profit of ₹5 Cr for the fiscal year ending March 2024, an improvement from a net loss of ₹1 Cr in the previous year. The operating profit margin (OPM) was reported at 3.15%, reflecting a modest level of profitability compared to industry norms, which typically range higher. The return on equity (ROE) stood at 24.7%, indicating effective utilization of shareholder funds, while the return on capital employed (ROCE) was at 21.3%, showcasing efficient capital management. However, the cash conversion cycle, which stood at 155 days, signals potential inefficiencies in inventory management and receivables collection. The company must focus on optimizing its operations to enhance profitability further while maintaining a balance between growth and operational efficiency.
Balance Sheet Strength and Financial Ratios
Bhaskar Agrochemicals’ balance sheet reflects both strengths and areas of concern. The company reported total borrowings of ₹20 Cr against reserves of ₹13 Cr, leading to a debt-to-equity ratio of 1.14, which is relatively high and may indicate financial risk. However, the interest coverage ratio (ICR) was a solid 4.56x, suggesting that the company can comfortably meet its interest obligations. The book value per share was ₹34.07 as of March 2025, indicating a reasonable asset backing for shareholders. The current ratio of 1.20 suggests adequate liquidity to cover short-term liabilities, while the quick ratio of 0.65 points to potential liquidity concerns. The financial ratios indicate a need for strategic debt management to strengthen the balance sheet and enhance financial stability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Bhaskar Agrochemicals reveals significant promoter confidence, with promoters holding 62.28% of the company. This high level of promoter ownership typically indicates a strong commitment to the firm’s long-term success. The public shareholding stood at 37.72%, with a total of 4,670 shareholders as of June 2025. While there is no foreign institutional investment (FIIs) or domestic institutional investment (DIIs) reported, the increasing number of individual shareholders suggests growing interest among retail investors. This could be a positive signal for the company’s future, as a diverse shareholder base can provide stability. However, the lack of institutional backing may limit the stock’s liquidity and perceived credibility in the broader market.
Outlook, Risks, and Final Insight
Looking ahead, Bhaskar Agrochemicals faces both opportunities and risks. The projected increase in sales to ₹91 Cr by March 2025 presents a strong growth potential, driven by rising agricultural demand. However, the company must address its operational inefficiencies, particularly the lengthy cash conversion cycle, to sustain profitability. Additionally, the high debt levels pose a risk, especially in fluctuating market conditions. Strengthening the balance sheet through better debt management and focusing on operational efficiencies can enhance financial health. Furthermore, external factors such as regulatory changes in the agrochemical sector and fluctuations in raw material prices could impact performance. Overall, while the outlook seems promising, prudent management of risks and operational strategies will be crucial for Bhaskar Agrochemicals to realize its growth potential.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Bhaskar Agrochemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 7,110 Cr. | 1,648 | 2,243/1,502 | 16.5 | 441 | 0.36 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 841 Cr. | 249 | 391/165 | 16.1 | 117 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 52.8 Cr. | 101 | 148/55.2 | 9.65 | 34.1 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 3,154 Cr. | 243 | 365/228 | 111 | 53.9 | 0.06 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 747 Cr. | 316 | 670/244 | 10.9 | 320 | 0.95 % | 12.9 % | 9.95 % | 10.0 |
| Industry Average | 11,432.90 Cr | 1,522.93 | 28.63 | 445.46 | 0.43% | 15.21% | 19.87% | 7.25 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.36 | 23.21 | 16.90 | 11.09 | 7.33 | 29.55 | 20.29 | 9.48 | 11.66 | 32.24 | 24.30 | 22.31 | 23.20 |
| Expenses | 5.87 | 19.56 | 14.18 | 11.92 | 9.19 | 24.27 | 17.25 | 9.87 | 13.18 | 26.89 | 20.91 | 20.49 | 22.47 |
| Operating Profit | -0.51 | 3.65 | 2.72 | -0.83 | -1.86 | 5.28 | 3.04 | -0.39 | -1.52 | 5.35 | 3.39 | 1.82 | 0.73 |
| OPM % | -9.51% | 15.73% | 16.09% | -7.48% | -25.38% | 17.87% | 14.98% | -4.11% | -13.04% | 16.59% | 13.95% | 8.16% | 3.15% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.02 | 0.00 | 0.01 | 0.06 | 0.00 |
| Interest | 0.39 | 0.41 | 0.44 | 0.47 | 0.48 | 0.46 | 0.46 | 0.47 | 0.44 | 0.37 | 0.45 | 0.74 | 0.48 |
| Depreciation | 0.29 | 0.30 | 0.30 | 0.31 | 0.36 | 0.41 | 0.40 | 0.41 | 0.42 | 0.43 | 0.44 | 0.45 | 0.43 |
| Profit before tax | -1.19 | 2.94 | 1.98 | -1.61 | -2.70 | 4.41 | 2.18 | -1.23 | -2.36 | 4.55 | 2.51 | 0.69 | -0.18 |
| Tax % | 62.18% | 28.91% | 28.79% | -32.92% | -24.81% | 27.66% | 32.11% | -27.64% | -24.15% | 30.33% | 29.08% | -7.25% | 16.67% |
| Net Profit | -1.94 | 2.10 | 1.41 | -1.08 | -2.03 | 3.19 | 1.48 | -0.90 | -1.78 | 3.17 | 1.77 | 0.74 | -0.21 |
| EPS in Rs | -3.72 | 4.03 | 2.71 | -2.07 | -3.90 | 6.12 | 2.84 | -1.73 | -3.42 | 6.08 | 3.40 | 1.42 | -0.40 |
Last Updated: August 19, 2025, 10:15 pm
Below is a detailed analysis of the quarterly data for Bhaskar Agrochemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 23.20 Cr.. The value appears strong and on an upward trend. It has increased from 22.31 Cr. (Mar 2025) to 23.20 Cr., marking an increase of 0.89 Cr..
- For Expenses, as of Jun 2025, the value is 22.47 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 20.49 Cr. (Mar 2025) to 22.47 Cr., marking an increase of 1.98 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.73 Cr.. The value appears to be declining and may need further review. It has decreased from 1.82 Cr. (Mar 2025) to 0.73 Cr., marking a decrease of 1.09 Cr..
- For OPM %, as of Jun 2025, the value is 3.15%. The value appears to be declining and may need further review. It has decreased from 8.16% (Mar 2025) to 3.15%, marking a decrease of 5.01%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.06 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.06 Cr..
- For Interest, as of Jun 2025, the value is 0.48 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.74 Cr. (Mar 2025) to 0.48 Cr., marking a decrease of 0.26 Cr..
- For Depreciation, as of Jun 2025, the value is 0.43 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.45 Cr. (Mar 2025) to 0.43 Cr., marking a decrease of 0.02 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.18 Cr.. The value appears to be declining and may need further review. It has decreased from 0.69 Cr. (Mar 2025) to -0.18 Cr., marking a decrease of 0.87 Cr..
- For Tax %, as of Jun 2025, the value is 16.67%. The value appears to be increasing, which may not be favorable. It has increased from -7.25% (Mar 2025) to 16.67%, marking an increase of 23.92%.
- For Net Profit, as of Jun 2025, the value is -0.21 Cr.. The value appears to be declining and may need further review. It has decreased from 0.74 Cr. (Mar 2025) to -0.21 Cr., marking a decrease of 0.95 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.40. The value appears to be declining and may need further review. It has decreased from 1.42 (Mar 2025) to -0.40, marking a decrease of 1.82.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:46 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 27 | 26 | 28 | 28 | 52 | 52 | 52 | 64 | 62 | 55 | 67 | 91 | 102 |
| Expenses | 26 | 25 | 26 | 26 | 50 | 49 | 49 | 61 | 57 | 50 | 61 | 81 | 91 |
| Operating Profit | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 5 | 5 | 6 | 9 | 11 |
| OPM % | 5% | 5% | 7% | 8% | 4% | 6% | 6% | 5% | 8% | 9% | 9% | 10% | 11% |
| Other Income | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Profit before tax | 1 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 2 | 2 | 3 | 5 | 8 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 44% | 88% | 34% | 28% | |
| Net Profit | 1 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 2 | 4 | 5 |
| EPS in Rs | 2.63 | 2.02 | 3.03 | 1.65 | 0.75 | 1.38 | 1.17 | 1.63 | 2.09 | 0.44 | 3.34 | 7.49 | 10.50 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 100.00% | -50.00% | -100.00% | 0.00% | 0.00% | 0.00% | -100.00% | 100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 100.00% | -150.00% | -50.00% | 100.00% | 0.00% | 0.00% | -100.00% | 200.00% |
Bhaskar Agrochemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 12% |
| 3 Years: | 13% |
| TTM: | 44% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 45% |
| 3 Years: | 40% |
| TTM: | 175% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 55% |
| 3 Years: | 43% |
| 1 Year: | 70% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 13% |
| 3 Years: | 14% |
| Last Year: | 25% |
Last Updated: September 5, 2025, 2:41 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -6.00 | -5.00 | -8.00 | -6.00 | -10.00 | -10.00 | -8.00 | -8.00 | -11.00 | -13.00 | -12.00 | -11.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 3 | 7 | 10 | 7 | 8 | 20 | 38 | 20 | 76 | 111 | 82 | 86 |
| Inventory Days | 66 | 73 | 73 | 97 | 65 | 75 | 48 | 66 | 109 | 114 | 142 | 133 |
| Days Payable | 51 | 65 | 34 | 39 | 28 | 34 | 30 | 71 | 91 | 108 | 97 | 64 |
| Cash Conversion Cycle | 18 | 15 | 49 | 65 | 45 | 61 | 56 | 15 | 95 | 116 | 128 | 155 |
| Working Capital Days | -16 | -19 | -28 | -43 | -31 | -39 | -36 | -17 | 4 | 6 | 22 | 26 |
| ROCE % | 20% | 14% | 17% | 12% | 8% | 10% | 9% | 11% | 17% | 12% | 15% | 21% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 7.48 | 3.34 | 0.45 | 2.09 | 1.63 |
| Diluted EPS (Rs.) | 7.48 | 3.34 | 0.45 | 2.09 | 1.63 |
| Cash EPS (Rs.) | 10.82 | 6.40 | 2.77 | 4.26 | 3.60 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 34.07 | 26.58 | 23.22 | 22.71 | 19.69 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 34.07 | 26.58 | 23.22 | 22.71 | 19.69 |
| Revenue From Operations / Share (Rs.) | 173.73 | 128.21 | 106.30 | 125.72 | 122.77 |
| PBDIT / Share (Rs.) | 17.54 | 11.74 | 9.18 | 9.99 | 6.18 |
| PBIT / Share (Rs.) | 14.21 | 8.70 | 6.86 | 7.82 | 4.21 |
| PBT / Share (Rs.) | 10.37 | 5.10 | 3.57 | 3.74 | 1.63 |
| Net Profit / Share (Rs.) | 7.48 | 3.35 | 0.45 | 2.09 | 1.63 |
| PBDIT Margin (%) | 10.09 | 9.16 | 8.63 | 7.94 | 5.03 |
| PBIT Margin (%) | 8.17 | 6.78 | 6.44 | 6.22 | 3.43 |
| PBT Margin (%) | 5.96 | 3.98 | 3.36 | 2.97 | 1.33 |
| Net Profit Margin (%) | 4.30 | 2.61 | 0.42 | 1.66 | 1.33 |
| Return on Networth / Equity (%) | 21.95 | 12.60 | 1.94 | 9.21 | 8.29 |
| Return on Capital Employeed (%) | 29.23 | 19.67 | 18.20 | 23.01 | 14.20 |
| Return On Assets (%) | 6.67 | 3.48 | 0.49 | 2.47 | 2.69 |
| Long Term Debt / Equity (X) | 0.25 | 0.25 | 0.23 | 0.15 | 0.28 |
| Total Debt / Equity (X) | 1.14 | 1.09 | 1.29 | 1.12 | 0.74 |
| Asset Turnover Ratio (%) | 1.67 | 1.37 | 1.21 | 1.73 | 2.09 |
| Current Ratio (X) | 1.20 | 0.58 | 1.03 | 1.02 | 0.81 |
| Quick Ratio (X) | 0.65 | 0.58 | 0.61 | 0.51 | 0.24 |
| Inventory Turnover Ratio (X) | 0.00 | 7.97 | 3.24 | 4.73 | 7.71 |
| Interest Coverage Ratio (X) | 4.56 | 3.27 | 2.80 | 3.78 | 2.39 |
| Interest Coverage Ratio (Post Tax) (X) | 2.95 | 1.93 | 1.14 | 2.34 | 1.63 |
| Enterprise Value (Cr.) | 60.74 | 48.27 | 55.23 | 49.51 | 26.33 |
| EV / Net Operating Revenue (X) | 0.67 | 0.72 | 0.99 | 0.75 | 0.41 |
| EV / EBITDA (X) | 6.65 | 7.91 | 11.58 | 9.54 | 8.20 |
| MarketCap / Net Operating Revenue (X) | 0.44 | 0.46 | 0.67 | 0.50 | 0.26 |
| Price / BV (X) | 2.29 | 2.22 | 3.09 | 2.81 | 1.63 |
| Price / Net Operating Revenue (X) | 0.44 | 0.46 | 0.67 | 0.50 | 0.26 |
| EarningsYield | 0.09 | 0.05 | 0.01 | 0.03 | 0.05 |
After reviewing the key financial ratios for Bhaskar Agrochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 3.34 (Mar 24) to 7.48, marking an increase of 4.14.
- For Diluted EPS (Rs.), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 3.34 (Mar 24) to 7.48, marking an increase of 4.14.
- For Cash EPS (Rs.), as of Mar 25, the value is 10.82. This value is within the healthy range. It has increased from 6.40 (Mar 24) to 10.82, marking an increase of 4.42.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 34.07. It has increased from 26.58 (Mar 24) to 34.07, marking an increase of 7.49.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 34.07. It has increased from 26.58 (Mar 24) to 34.07, marking an increase of 7.49.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 173.73. It has increased from 128.21 (Mar 24) to 173.73, marking an increase of 45.52.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 17.54. This value is within the healthy range. It has increased from 11.74 (Mar 24) to 17.54, marking an increase of 5.80.
- For PBIT / Share (Rs.), as of Mar 25, the value is 14.21. This value is within the healthy range. It has increased from 8.70 (Mar 24) to 14.21, marking an increase of 5.51.
- For PBT / Share (Rs.), as of Mar 25, the value is 10.37. This value is within the healthy range. It has increased from 5.10 (Mar 24) to 10.37, marking an increase of 5.27.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 3.35 (Mar 24) to 7.48, marking an increase of 4.13.
- For PBDIT Margin (%), as of Mar 25, the value is 10.09. This value is within the healthy range. It has increased from 9.16 (Mar 24) to 10.09, marking an increase of 0.93.
- For PBIT Margin (%), as of Mar 25, the value is 8.17. This value is below the healthy minimum of 10. It has increased from 6.78 (Mar 24) to 8.17, marking an increase of 1.39.
- For PBT Margin (%), as of Mar 25, the value is 5.96. This value is below the healthy minimum of 10. It has increased from 3.98 (Mar 24) to 5.96, marking an increase of 1.98.
- For Net Profit Margin (%), as of Mar 25, the value is 4.30. This value is below the healthy minimum of 5. It has increased from 2.61 (Mar 24) to 4.30, marking an increase of 1.69.
- For Return on Networth / Equity (%), as of Mar 25, the value is 21.95. This value is within the healthy range. It has increased from 12.60 (Mar 24) to 21.95, marking an increase of 9.35.
- For Return on Capital Employeed (%), as of Mar 25, the value is 29.23. This value is within the healthy range. It has increased from 19.67 (Mar 24) to 29.23, marking an increase of 9.56.
- For Return On Assets (%), as of Mar 25, the value is 6.67. This value is within the healthy range. It has increased from 3.48 (Mar 24) to 6.67, marking an increase of 3.19.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.25. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.25.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.14. This value exceeds the healthy maximum of 1. It has increased from 1.09 (Mar 24) to 1.14, marking an increase of 0.05.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.67. It has increased from 1.37 (Mar 24) to 1.67, marking an increase of 0.30.
- For Current Ratio (X), as of Mar 25, the value is 1.20. This value is below the healthy minimum of 1.5. It has increased from 0.58 (Mar 24) to 1.20, marking an increase of 0.62.
- For Quick Ratio (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.58 (Mar 24) to 0.65, marking an increase of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 7.97 (Mar 24) to 0.00, marking a decrease of 7.97.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.56. This value is within the healthy range. It has increased from 3.27 (Mar 24) to 4.56, marking an increase of 1.29.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.95. This value is below the healthy minimum of 3. It has increased from 1.93 (Mar 24) to 2.95, marking an increase of 1.02.
- For Enterprise Value (Cr.), as of Mar 25, the value is 60.74. It has increased from 48.27 (Mar 24) to 60.74, marking an increase of 12.47.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 0.72 (Mar 24) to 0.67, marking a decrease of 0.05.
- For EV / EBITDA (X), as of Mar 25, the value is 6.65. This value is within the healthy range. It has decreased from 7.91 (Mar 24) to 6.65, marking a decrease of 1.26.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.46 (Mar 24) to 0.44, marking a decrease of 0.02.
- For Price / BV (X), as of Mar 25, the value is 2.29. This value is within the healthy range. It has increased from 2.22 (Mar 24) to 2.29, marking an increase of 0.07.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.46 (Mar 24) to 0.44, marking a decrease of 0.02.
- For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.09, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bhaskar Agrochemicals Ltd:
- Net Profit Margin: 4.3%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 29.23% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 21.95% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.95
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.65
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 9.65 (Industry average Stock P/E: 28.63)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.14
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.3%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | D. No.1-90/C, Office Unit-608,1T06, 6th Floor. Gowra Fountain Head, Hyderabad Telangana 500081 | bhaskaragro@yahoo.com http://www.bhaskaragro.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. P Pattabhi Rama Rao | Chairman & Managing Director |
| Mr. P Praveen Kumar | Joint Managing Director & CFO |
| Dr. Aluri Naga Uma Maheswara Prasad | Non Executive Director |
| Mrs. P Rajyalaxmi | Non Executive Director |
| Mr. S V Satyanarayana Chowdary | Independent Director |
| Mr. Sudhakar | Independent Director |